Fluid and electrolyte secretion in the inflamed gut: Novel targets for treatment of inflammation-induced diarrhea

Melanie Gareau, Kim E. Barrett

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Diarrheal disease can occur in the context of both inflammatory and infectious challenges. Inflammation can result in changes in ion transporter expression or simply mislocalization of the protein. In addition to development of diarrhea, an altered secretory state can lead to changes in mucus secretion and luminal pH. Bacterial infection can lead to subversion of host cell signaling, leading to transporter mislocalization and hyposecretion, promoting bacterial colonization. Novel therapeutic strategies are currently being developed to ameliorate transporter defects in the setting of inflammation or bacterial infection including, for example, administration of probiotics and fecal microbiota transplantation. This review will highlight recent findings in the literature detailing these aspects of ion transport in the inflamed gut.

Original languageEnglish (US)
Pages (from-to)895-899
Number of pages5
JournalCurrent Opinion in Pharmacology
Volume13
Issue number6
DOIs
StatePublished - 2013

Fingerprint

Fluids and Secretions
Bacterial Infections
Electrolytes
Diarrhea
Inflammation
Ion Transport
Probiotics
Mucus
Ions
Therapeutics
Proteins
Fecal Microbiota Transplantation

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

Fluid and electrolyte secretion in the inflamed gut : Novel targets for treatment of inflammation-induced diarrhea. / Gareau, Melanie; Barrett, Kim E.

In: Current Opinion in Pharmacology, Vol. 13, No. 6, 2013, p. 895-899.

Research output: Contribution to journalArticle

@article{0600e0d4bfc44fc1b96ca5cc94c07077,
title = "Fluid and electrolyte secretion in the inflamed gut: Novel targets for treatment of inflammation-induced diarrhea",
abstract = "Diarrheal disease can occur in the context of both inflammatory and infectious challenges. Inflammation can result in changes in ion transporter expression or simply mislocalization of the protein. In addition to development of diarrhea, an altered secretory state can lead to changes in mucus secretion and luminal pH. Bacterial infection can lead to subversion of host cell signaling, leading to transporter mislocalization and hyposecretion, promoting bacterial colonization. Novel therapeutic strategies are currently being developed to ameliorate transporter defects in the setting of inflammation or bacterial infection including, for example, administration of probiotics and fecal microbiota transplantation. This review will highlight recent findings in the literature detailing these aspects of ion transport in the inflamed gut.",
author = "Melanie Gareau and Barrett, {Kim E.}",
year = "2013",
doi = "10.1016/j.coph.2013.08.014",
language = "English (US)",
volume = "13",
pages = "895--899",
journal = "Current Opinion in Pharmacology",
issn = "1471-4892",
publisher = "Elsevier BV",
number = "6",

}

TY - JOUR

T1 - Fluid and electrolyte secretion in the inflamed gut

T2 - Novel targets for treatment of inflammation-induced diarrhea

AU - Gareau, Melanie

AU - Barrett, Kim E.

PY - 2013

Y1 - 2013

N2 - Diarrheal disease can occur in the context of both inflammatory and infectious challenges. Inflammation can result in changes in ion transporter expression or simply mislocalization of the protein. In addition to development of diarrhea, an altered secretory state can lead to changes in mucus secretion and luminal pH. Bacterial infection can lead to subversion of host cell signaling, leading to transporter mislocalization and hyposecretion, promoting bacterial colonization. Novel therapeutic strategies are currently being developed to ameliorate transporter defects in the setting of inflammation or bacterial infection including, for example, administration of probiotics and fecal microbiota transplantation. This review will highlight recent findings in the literature detailing these aspects of ion transport in the inflamed gut.

AB - Diarrheal disease can occur in the context of both inflammatory and infectious challenges. Inflammation can result in changes in ion transporter expression or simply mislocalization of the protein. In addition to development of diarrhea, an altered secretory state can lead to changes in mucus secretion and luminal pH. Bacterial infection can lead to subversion of host cell signaling, leading to transporter mislocalization and hyposecretion, promoting bacterial colonization. Novel therapeutic strategies are currently being developed to ameliorate transporter defects in the setting of inflammation or bacterial infection including, for example, administration of probiotics and fecal microbiota transplantation. This review will highlight recent findings in the literature detailing these aspects of ion transport in the inflamed gut.

UR - http://www.scopus.com/inward/record.url?scp=84888202211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888202211&partnerID=8YFLogxK

U2 - 10.1016/j.coph.2013.08.014

DO - 10.1016/j.coph.2013.08.014

M3 - Article

C2 - 24054811

AN - SCOPUS:84888202211

VL - 13

SP - 895

EP - 899

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

IS - 6

ER -